News | March 26, 2015

Siemens Launches New Angiography System, Imaging Apps, POC Testing at ACC 2015

Floor-mounted Artis one addresses range of routine interventions; new ultrasound apps suite offers offline cardiology analysis package

March 26, 2015 — Siemens Healthcare introduced a new angiography system and new cardiac ultrasound apps at the 2015 American College of Cardiology (ACC) annual meeting. 
 
The new PURE platform for Siemens’ Artis zee, Artis Q, and Artis Q.zen angiography systems is designed to simplify the adoption and utilization of advanced features by adding smooth use to existing smart technologies while maintaining high standards in image quality and dose reduction. For 3-D acquisitions, the 3-D Wizard feature enables the user to simply click on the desired resultant image type from multiple model images for each part of the body. It automatically predefines all necessary parameters —including amount and injection rate of contrast fluid, X-ray delay, and other specifications — to create a 3-D image. The QuickZoom feature allows physicians to click on the point of interest on syngoDynaCT images, which is then locked automatically into the center of the image while rotating the 3-D dataset or adjusting the zoom factor with a simple joystick motion. The syngo 2-D/3-D Fusion feature enables fusion of a preprocedural volume (computed tomography (CT), magnetic resonance imaging (MRI), or positron emission tomography (PET]) utilizing just two fluoroscopic images for live image guidance.
 
Driving Outcomes in Cardiology
syngo Dynamics VA10B, the latest version of Siemens’ cardiovascular imaging and information system, boosts noninvasive and invasive cardiovascular reading and reporting workflows, allowing cardiologists to focus on clinical care rather than spend time with reporting. syngo Dynamics offers enhanced integration with Siemens Sensis hemodynamic monitoring system, enabling customers to benefit from a seamless workflow for cardiac catheterizations. syngoDynamics’ proven integration capabilities optimize clinical utilization and productivity, and enable support of enterprise-wide cardiovascular care initiatives.
 
Siemens’ new syngo Ultrasound Apps Suite is an advanced offline cardiology analysis package integrated with an institution’s picture archiving and communications system (PACS).  Seamlessly integrated with syngo Dynamics, syngo Ultrasound Apps Suite improves user productivity without requiring additional offline hardware. It includes as an offline option the one-click eSie Valves quantification software, which was introduced last fall on Siemens’ Acuson SC2000 Prime cardiovascular ultrasound system. eSie Valves improves diagnostic accuracy during diagnostic echo as well as valve interventions such as aortic and mitral valve repairs. Other clinical applications available on syngo Ultrasound Apps Suite include eSie LVA for automated left ventricular analysis and eSie PISA for assessment of mitral regurgitation.
 
Revolutionizing 3-D Transesophageal Ultrasound
The Acuson SC2000 ultrasound system Prime enables users to perform real-time, full-volume color Doppler, 3-D transesophageal ultrasound (TEE). The system provides real-time information in the OR to support a faster, more precise surgical workflow, optimize patient outcomes, and minimize risk. Full volume color Doppler and fast, automated aortic and mitral valve measurements provided by Siemens’ eSie Valves quantification software allow surgeons to better visualize cardiac anatomy and assess blood flow during procedures, helping them make faster, more informed decisions.
 
Providing Quantitative Cardiac Assays
A comprehensive portfolio of assays such as cTnI, BNP, NT-proBNP, and CardioPhase hsCRP helps manage patients throughout the continuum of cardiovascular disease. Siemens offers troponin testing on several of its core testing platforms, including Advia Centaur systems, Dimension Vista systems, and Dimension EXL systems, and provides consistent results by offering true clinical concordance between the point of care and central laboratory for guideline-compliant sensitive cardiac troponin. The Stratus CS Acute Care Diagnostics System provides quantitative cardiac assays for fast, accurate evaluation of patients presenting with acute myocardial infarction (AMI) at the point of care. These assays include the Stratus CS Acute Care Troponin I method (cTnl),  which, by helping to improve the diagnostic accuracy and rapid detection of AMI, facilitates earlier detection of myocardial injury, enabling more rapid diagnosis and faster initiation of appropriate therapy.
 
For more information:www.siemens.com
 

Related Content

Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing| September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referra
News | Blood Testing| May 02, 2017
CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in...
New Blood Test Predicts Major Cardiac Events Better Than Clinical Evaluation of Other Common Risk Factors
News | Blood Testing| April 28, 2017
Prevencio Inc. announced the publication of data demonstrating that a simple new blood test is more accurate than...
New Study Pursues Universal Sample Bank for Troponin Tests
News | Blood Testing| April 13, 2017
April 13, 2017 — A study published recently in the American Association for Clinical Chemistry’s (AACC)...
PTS Diagnostics, FDA 510k clearance, extended HDL range, lipid panel test strips
News | Blood Testing| April 05, 2017
PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded top range for...
heart attack evaluation, blood test, HEART Score, ER, emergency room, Circulation Cardiovascular Quality and Outcomes study
News | Blood Testing| March 01, 2017
Up to 40 percent of emergency room (ER) patients with chest pain can safely go home in a little under 2 hours, using a...
troponin blood test, heart disease risk, heart attack, British Heart Foundation, BHF
News | Blood Testing| January 04, 2017
A high-sensitivity blood test could be used to predict which patients are at risk of a heart attack according to new...
Alere, INRatio PT/INR Monitor, voluntary recall, FDA
News | Blood Testing| July 12, 2016
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc.
News | Blood Testing| March 22, 2016
March 22, 2016 — Critical Diagnostics announced that it entered into a license agreement for the exclusive worldwide
Overlay Init